Overview

The GMO U.S. Equity Fund seeks to generate high total return by investing primarily in U.S. equities. The Fund measures its performance against the S&P Composite 1500+ Index. 

The Fund’s investment approach is grounded in the Systematic Equity team’s belief that, in the short term, equity markets exhibit exploitable inefficiencies as a result of irrational investor actions, the imperfect flow of information, and the participation of non-economic actors, while in the long-term returns are ultimately driven by economic reality. The Fund aims to take advantage of these inefficiencies by utilizing a multi-factor valuation model in conjunction with other methods, such as cross-asset signals and corporate alerts, to identify undervalued equity securities. 

Facts

Doc Table
Fund Inception Date September 18, 1985
CUSIP 362013658
Fund Total Assets as of 9/30/2024 $138mm USD

Share Class III

Inception Date September 16, 2005
Ticker Symbol GMUEX
CUSIP 362013658
NAV as of 10/11/2024 14.55
Net Expense Ratio 1 0.48
Gross Expense Ratio 2 0.53
Minimum Investment Size $1mm in GMO

1 Net Expense Ratio reflects the reduction of expenses from fee reimbursements. The fee reimbursements will continue until at least June 30, 2025. Elimination of this reimbursement will result in higher fees and lower performance.

2 Gross Expense Ratio is equal to the Funds Total Annual Operating Expenses set forth in the Funds most recent prospectus dated June 30, 2024.

Performance

Quarter-End as of September 30, 2024(USD, %) | U.S. Equity Fund-III

Table Caption
1-Year 3-Year 5-Year 10-Year ITD
U.S. Equity Fund 33.22 12.44 15.52 12.05 11.44
S&P Composite 1500 35.54 11.46 15.58 13.11
  • U.S. Equity Fund 1
  • S&P Composite 1500

Inception Date: September 18, 1985

Returns shown for periods greater than one year are on an annualized basis.

If certain expenses were not reimbursed, performance would be lower. Transaction costs, if any, are paid to the fund to offset the cost of portfolio transactions to invest or raise cash.

1 Performance data quoted represents past performance and is not indicative of future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance data may be lower or higher than the performance data provided herein. The portfolio is not managed relative to a benchmark. References to an index are for informational purposes only. Performance information presented is that of Class III shares of GMO U.S. Core Fund for all periods ending on or before September 16, 2005.

Quarter-End as of September 30, 2024(USD, %) | U.S. Equity Fund-III

Table Caption
QTD YTD 1-Year 3-Year 5-Year 10-Year ITD
U.S. Equity Fund 4.41 19.78 33.22 12.44 15.52 12.05 11.44
S&P Composite 1500 6.04 21.26 35.54 11.46 15.58 13.11
  • U.S. Equity Fund 1
  • S&P Composite 1500

Inception Date: September 18, 1985

Returns shown for periods greater than one year are on an annualized basis.

Net of all fees and expenses after reimbursement by the Manager, but not transaction costs, if any. If certain expenses were not reimbursed, performance would be lower.

1 Performance data quoted represents past performance and is not indicative of future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance data may be lower or higher than the performance data provided herein. The portfolio is not managed relative to a benchmark. References to an index are for informational purposes only. Performance information presented is that of Class III shares of GMO U.S. Core Fund for all periods ending on or before September 16, 2005.

Quarter-End as of September 30, 2024(USD, %) | U.S. Equity Fund-III

Table Caption
QTD YTD 1-Year 3-Year 5-Year 10-Year ITD
U.S. Equity Fund 4.53 20.22 33.87 12.97 16.07 12.57 11.97
S&P Composite 1500 6.04 21.26 35.54 11.46 15.58 13.11
  • U.S. Equity Fund 1
  • S&P Composite 1500

Inception Date: September 18, 1985

Returns shown for periods greater than one year are on an annualized basis.

Gross of fees, expenses and transaction costs, if any. If these fees, expenses and costs were included, performance would be lower.

1 Performance data quoted represents past performance and is not indicative of future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance data may be lower or higher than the performance data provided herein. The portfolio is not managed relative to a benchmark. References to an index are for informational purposes only. Performance information presented is that of Class III shares of GMO U.S. Core Fund for all periods ending on or before September 16, 2005.

Month-End as of September 30, 2024(USD, %) | U.S. Equity Fund-III

Table Caption
MTD QTD YTD 1-Year 3-Year 5-Year 10-Year ITD
U.S. Equity Fund 1.33 4.41 19.78 33.22 12.44 15.52 12.05 11.44
S&P Composite 1500 2.05 6.04 21.26 35.54 11.46 15.58 13.11
  • U.S. Equity Fund 1
  • S&P Composite 1500

Inception Date: September 18, 1985

Returns shown for periods greater than one year are on an annualized basis.

Net of all fees and expenses after reimbursement by the Manager, but not transaction costs, if any. If certain expenses were not reimbursed, performance would be lower.

1 Performance data quoted represents past performance and is not indicative of future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance data may be lower or higher than the performance data provided herein. The portfolio is not managed relative to a benchmark. References to an index are for informational purposes only. Performance information presented is that of Class III shares of GMO U.S. Core Fund for all periods ending on or before September 16, 2005.

Month-End as of September 30, 2024(USD, %) | U.S. Equity Fund-III

Table Caption
MTD QTD YTD 1-Year 3-Year 5-Year 10-Year ITD
U.S. Equity Fund 1.37 4.53 20.22 33.87 12.97 16.07 12.57 11.97
S&P Composite 1500 2.05 6.04 21.26 35.54 11.46 15.58 13.11
  • U.S. Equity Fund 1
  • S&P Composite 1500

Inception Date: September 18, 1985

Returns shown for periods greater than one year are on an annualized basis.

Gross of fees, expenses and transaction costs, if any. If these fees, expenses and costs were included, performance would be lower.

1 Performance data quoted represents past performance and is not indicative of future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance data may be lower or higher than the performance data provided herein. The portfolio is not managed relative to a benchmark. References to an index are for informational purposes only. Performance information presented is that of Class III shares of GMO U.S. Core Fund for all periods ending on or before September 16, 2005.

Year Ending December 31 (USD, %) | U.S. Equity Fund-III

Calendar
U.S. Equity Fund S&P Composite 1500
2023 21.88 25.47
2022 -12.44 -17.78
2021 32.13 28.45
2020 13.69 17.92
2019 28.57 30.90
2018 -9.78 -4.96
2017 18.46 21.13
2016 13.58 13.03
2015 0.65 1.01
2014 9.27 13.08
  • U.S. Equity Fund 1
  • S&P Composite 1500

Inception Date: September 18, 1985

Returns shown for periods greater than one year are on an annualized basis.

Net of all fees and expenses after reimbursement by the Manager, but not transaction costs, if any. If certain expenses were not reimbursed, performance would be lower.

1 Performance data quoted represents past performance and is not indicative of future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance data may be lower or higher than the performance data provided herein. The portfolio is not managed relative to a benchmark. References to an index are for informational purposes only. Performance information presented is that of Class III shares of GMO U.S. Core Fund for all periods ending on or before September 16, 2005.

Year Ending December 31 (USD, %) | U.S. Equity Fund-III

Calendar
U.S. Equity Fund S&P Composite 1500
2023 22.46 25.47
2022 -12.02 -17.78
2021 32.73 28.45
2020 14.22 17.92
2019 29.16 30.90
2018 -9.36 -4.96
2017 19.00 21.13
2016 14.10 13.03
2015 1.11 1.01
2014 9.77 13.08
  • U.S. Equity Fund 1
  • S&P Composite 1500

Inception Date: September 18, 1985

Returns shown for periods greater than one year are on an annualized basis.

Gross of fees, expenses and transaction costs, if any. If these fees, expenses and costs were included, performance would be lower.

1 Performance data quoted represents past performance and is not indicative of future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance data may be lower or higher than the performance data provided herein. The portfolio is not managed relative to a benchmark. References to an index are for informational purposes only. Performance information presented is that of Class III shares of GMO U.S. Core Fund for all periods ending on or before September 16, 2005.

Documents

Literature

Fact Sheet Download
Prospectus Download
Summary Prospectus Download
Statement of Additional Information Download
Download All Download

Downloads

Performance Download
Portfolio Composition Download
Holdings Download
Download All Download

Commentary & Attribution

Commentary Quarterly Download
Market Review Download
Attribution - Monthly Download
Attribution - Quarterly Download
Attribution - YTD Download
Download All Download

Investor Information

Annual Report Download
Semi-Annual Report Download
NAVs and Distributions Download
Distribution Dates Download
Tax-Related Distribution Information Download
Download All Download

Risks

Risks associated with investing in the Fund may include: (1) Market Risk - Equities: The market price of equities may decline due to factors affecting the issuer, its industries, or the economy and equity markets generally. Declines in stock market prices generally are likely to reduce the net asset value of the Fund's shares. (2) Management and Operational Risk: The risk that GMO's investment techniques will fail to produce desired results, including annualized returns and annualized volatility. (3) Focused Investment Risk: The Fund invests its assets in the securities of a limited number of issuers, and a decline in the market price of a particular security held by the Fund may affect the Fund's performance more than if the Fund invested in the securities of a larger number of issuers.For a more complete discussion of these risks and others, please consult the Fund's Prospectus.

Disclosures

An investor should consider the fund’s investment objectives, risks, charges and expenses before investing. This and other important information can be found in the fund’s prospectus. Read the prospectus carefully before investing. Please see prospectus above.

The GMO Trust funds are distributed in the United States by Funds Distributor LLC. GMO and Funds Distributor LLC are not affiliated.